Appropriateness to set a group health-based guidance value for zearalenone and its modified forms
dc.contributor.author | Wallace, Heather | |
dc.contributor.author | Jan, Alexander | |
dc.contributor.author | Barregård, Lars | |
dc.contributor.author | Bignami, Margherita | |
dc.contributor.author | Ceccatelli, Sandra | |
dc.contributor.author | Cottrill, Bruce | |
dc.contributor.author | Dinovi, Michael | |
dc.contributor.author | Edler, Lutz | |
dc.contributor.author | Grasl-Kraupp, Bettina | |
dc.contributor.author | Hogstrand, Christer | |
dc.contributor.author | Hoogenboom, Laurentius (Ron) | |
dc.contributor.author | Knutsen, Helle Katrine | |
dc.contributor.author | Nebbia, Carlo Stefano | |
dc.contributor.author | Oswald, Isabelle | |
dc.contributor.author | Petersen, Annette | |
dc.contributor.author | Rogiers, Vera Maria | |
dc.contributor.author | Rose, Martin | |
dc.contributor.author | Roudot, Alain-Claude | |
dc.contributor.author | Schwerdtle, Tanja | |
dc.contributor.author | Vleminckx, Christiane | |
dc.contributor.author | Vollmer, Günter | |
dc.contributor.author | EFSA Panel on Contaminants in the Food Chain (CONTAM) | |
dc.date.accessioned | 2016-12-01T14:28:15Z | |
dc.date.available | 2016-12-01T14:28:15Z | |
dc.date.issued | 2016-04 | |
dc.identifier | 73318874 | |
dc.identifier | d2df2d5c-ad33-4238-a949-6b1bce788af2 | |
dc.identifier | 85096589150 | |
dc.identifier.citation | Wallace , H , Jan , A , Barregård , L , Bignami , M , Ceccatelli , S , Cottrill , B , Dinovi , M , Edler , L , Grasl-Kraupp , B , Hogstrand , C , Hoogenboom , L , Knutsen , H K , Nebbia , C S , Oswald , I , Petersen , A , Rogiers , V M , Rose , M , Roudot , A-C , Schwerdtle , T , Vleminckx , C , Vollmer , G & EFSA Panel on Contaminants in the Food Chain (CONTAM) 2016 , ' Appropriateness to set a group health-based guidance value for zearalenone and its modified forms ' , EFSA Journal , vol. 14 , no. 4 , 4425 , pp. 1-46 . https://doi.org/10.2903/j.efsa.2016.4425 | en |
dc.identifier.issn | 1831-4732 | |
dc.identifier.uri | http://hdl.handle.net/2164/7792 | |
dc.description | The Panel wishes to thank the members of the Working Group on group HBGVs for mycotoxins and their modified forms: Jan Alexander, Chiara Dall’Asta, Arno Gutleb, Manfred Metzler, Isabelle Oswald and Dominique Parent-Massin for the preparatory work on this scientific opinion, and the EFSA staff member Hans Steinkellner for the support provided to this scientific opinion. | en |
dc.format.extent | 46 | |
dc.format.extent | 21578 | |
dc.language.iso | eng | |
dc.relation.ispartof | EFSA Journal | en |
dc.subject | zearalenone | en |
dc.subject | modified forms | en |
dc.subject | metabolites | en |
dc.subject | group tolerable daily intake | en |
dc.subject | oestrogenicity | en |
dc.subject | relative potency factors | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Appropriateness to set a group health-based guidance value for zearalenone and its modified forms | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.2903/j.efsa.2016.4425 | |
dc.identifier.vol | 14 | en |
dc.identifier.iss | 4 | en |